The Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial study recently demonstrated that administration of high doses of omega-3 fatty acids confers cardiovascular benefit in high-risk patients with the modest hypertriglyceridemia. This provided optimism for a therapeutic area that has challenged the field of cardiovascular…[Read more]